Our study highlights that the phagocytosis checkpoints of CD47/SIRPα and PD-1/PD-L1 axes are highly correlated with poor progression among ICC patients, while those of the CD24/SIGLEC10 and MHC-I/LILRB1 axes are not. The gene discussed is SIRPA; the disease is intrahepatic cholangiocarcinoma.